FDA links once-promising pain drugs to bone decay
Thursday, March 8, 2012 - 10:02
in Health & Medicine
WASHINGTON (AP) -- Some of the world's largest drugmakers will face an uphill battle next week in their bid to revive a class of experimental arthritis drugs that have been sidelined by safety concerns for nearly two years....